Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIBELULA
NCT06129539Phase 3Active, not recruiting
- Sponsor
- Debiopharm
- Start
- Jul 2024
- Primary completion
- Oct 2026
- Modality
- Peptides, Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of triptorelin in central precocious puberty (CPP), sponsored by Debiopharm. Started Jul 2024; status: active, not recruiting.
02
Drugs
triptorelin
03
Conditions
central precocious puberty (CPP)
Beyond the preview
Go deeper on NCT06129539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06129539.